Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Sandra Kim, MD
Conference Coverage
Sandra Kim, MD, on Costs of and Access to Care for Pediatric Patients With IBD
12/11/2021
Dr Kim discussed the barriers and delays created by costs of care during a clinical workshop on pediatric patients at the Advances in Inflammatory Bowel Disease meeting on December 10.
Dr Kim discussed the barriers and delays created by costs of care during a clinical workshop on pediatric patients at the Advances in Inflammatory Bowel Disease meeting on December 10.
Dr Kim discussed the barriers...
12/11/2021
Advances in Inflammatory Bowel Disease Network
Holubar
Conference Coverage
Stefan Holubar, MD, on the ABCs of Ileocolonic Anastamosis
12/11/2021
Dr Holubar reviews his keynote address from AIBD on the pros and cons of different surgical techniques used in ileocolonic anastamosis for the treatment of Crohn disease.
Dr Holubar reviews his keynote address from AIBD on the pros and cons of different surgical techniques used in ileocolonic anastamosis for the treatment of Crohn disease.
Dr Holubar reviews his keynote...
12/11/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Rahul Dalal, MD
Conference Coverage
Rahul Dalal, MD: Poster Award Winner
12/11/2021
Dr Dalal, from Brigham & Women's Medical Center, reviews his award-winning poster presentation on "Comparative Risk of Clostridioides difficile Infection in Vedolizumab vs anti-TNF Agents in Biologic-Naive Patients With Ulcerative Colitis."
Dr Dalal, from Brigham & Women's Medical Center, reviews his award-winning poster presentation on "Comparative Risk of Clostridioides difficile Infection in Vedolizumab vs anti-TNF Agents in Biologic-Naive Patients With Ulcerative Colitis."
Dr Dalal, from Brigham & Women's...
12/11/2021
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro, MD
Conference Coverage
Miguel Regueiro, MD, on IBD Care of the Future
12/10/2021
Dr Regueiro, chair for Digestive Disease and Surgery Institute at Cleveland Clinic in Cleveland, Ohio, delivered the Rick MacDermott Lecture in Advanced and Multidisciplinary Care in IBD at AIBD on the future of IBD care, emphasizing the...
Dr Regueiro, chair for Digestive Disease and Surgery Institute at Cleveland Clinic in Cleveland, Ohio, delivered the Rick MacDermott Lecture in Advanced and Multidisciplinary Care in IBD at AIBD on the future of IBD care, emphasizing the...
Dr Regueiro, chair for...
12/10/2021
Advances in Inflammatory Bowel Disease Network
Edward Loftus, MD
Conference Coverage
Edward Loftus, MD, on Managing Cardiovascular Risk in IBD in a New Era
12/10/2021
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews his keynote address on increasing indications that patients with IBD may be at higher risk for cardiovascular diseases (CVD), and the importance of surveillance for CVD symptoms...
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews his keynote address on increasing indications that patients with IBD may be at higher risk for cardiovascular diseases (CVD), and the importance of surveillance for CVD symptoms...
Dr Loftus, from the Mayo Clinic...
12/10/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

David Rubin, MD
Conference Coverage
David Rubin, MD, on Preparing for IBD Care in the Next Pandemic
12/10/2021
Dr Rubin, from the University of Chicago, details his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for...
Dr Rubin, from the University of Chicago, details his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for...
Dr Rubin, from the University of...
12/10/2021
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer, MD
Conference Coverage
Stephen Hanauer, MD, on the Past, Present, and Future of IBD Pharmacology
12/10/2021
Dr Hanauer reviews his keynote address from December 9 at Advances in Inflammatory Bowel Diseases 2021 on advances in pharmacology for the treatment of IBD from the advent of sulfasalazine to today’s biologics and small molecules.
Dr Hanauer reviews his keynote address from December 9 at Advances in Inflammatory Bowel Diseases 2021 on advances in pharmacology for the treatment of IBD from the advent of sulfasalazine to today’s biologics and small molecules.
Dr Hanauer reviews his keynote...
12/10/2021
Advances in Inflammatory Bowel Disease Network
Gilaad Kaplan, MD
Conference Coverage
Gilaad Kaplan, MD, on the Epidemiology of IBD
12/10/2021
Dr Kaplan discusses his talk at Advances in Inflammatory Bowel Diseases about the 4 epidemiological stages of IBD and the challenges facing Western nations as prevalence rises among an aging population.
Dr Kaplan discusses his talk at Advances in Inflammatory Bowel Diseases about the 4 epidemiological stages of IBD and the challenges facing Western nations as prevalence rises among an aging population.
Dr Kaplan discusses his talk at...
12/10/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Maria Abreu, MD
Conference Coverage
Maria Abreu, MD, on the Pathogenesis of IBD: Closer to a Cure?
12/10/2021
Dr Abreu, from the University of Miami, reviews her presentation on the progress toward understanding the multifactorial nature of inflammatory bowel disease and how this makes finding an eventual cure especially challenging.
Dr Abreu, from the University of Miami, reviews her presentation on the progress toward understanding the multifactorial nature of inflammatory bowel disease and how this makes finding an eventual cure especially challenging.
Dr Abreu, from the University of...
12/10/2021
Advances in Inflammatory Bowel Disease Network
A. Sidney Barritt, IV, MD
Conference Coverage
Liver Abnormalities to Consider when Treating Patients with IBD
12/10/2021
At the AIBD 2021 annual meeting, A. Sidney Barritt IV, MD, the director of the University of North Carolina Liver Center, presented on the different liver abnormalities that can affect patients with IBD.
At the AIBD 2021 annual meeting, A. Sidney Barritt IV, MD, the director of the University of North Carolina Liver Center, presented on the different liver abnormalities that can affect patients with IBD.
At the AIBD 2021 annual meeting,...
12/10/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
10/23/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
10/23/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use